Fractalkine/CX3CL1: a potential new target for inflammatory diseases.
Department of Pharmacology, College of Pharmacy, University of Toledo, OH, USA.
Brian A
BA
Jones
Maria
M
Beamer
Salahuddin
S
Ahmed
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D054428:Chemokine CX3CL1 / Q000037:antagonists & inhibitors* / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D008954:Models, Biological; D008958:Models, Molecular
D000893:Anti-Inflammatory Agents; D054428:Chemokine CX3CL1